CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

NCT01243424 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6103

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: linagliptin
DRUG: glimepiride
DRUG: linagliptin placebo
DRUG: glimepiride placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]